Zum Hauptinhalt springen

Naloxon

08. November 2022 | Naloxon

Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program.

Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program. Ericson ØB, Eide D, Lobmaier P, Clausen T. Drug Alcohol Depend. 2022 Nov 1;240:109645. doi: 10.1016/j.drugal…

08. November 2022 | Naloxon

Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose.

Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose. Disney A, Olson KM, Shafer AM, Moore SC, Anand JP, Traynor JR, Husbands SM. ACS Chem Neurosci. 2022 Nov 2;13(21):3108-3117. doi: 10.1021/acsch…

01. November 2022 | Naloxon

Die 7. Nationale Substitutionskonferenz (NaSuKo) 21.09.2022 in Berlin - Beiträge zum Nachlesen oder Download

Die 7. Nationale Substitutionskonferenz (NaSuKo) 21.09.2022 in Berlin - Beiträge zum Nachlesen oder Download Hier stehen Ihnen die Beiträge der 7. NaSuKo zum Nachlesen oder Download zur Verfügung: – NALtrain – Rettet Leben; Simon Fleissn…

01. November 2022 | Naloxon

Attitude changes following short-form opioid overdose video education: a pilot study.

Attitude changes following short-form opioid overdose video education: a pilot study. Galiher MV, Huffman M. Harm Reduct J. 2022 Oct 14;19(1):114. doi: 10.1186/s12954-022-00696-4. PMID: 36241995; PMCID: PMC9562080. https://www.ncbi.nl…

01. November 2022 | Naloxon

Naloxone administration by law enforcement officers in New York State (2015-2020).

Naloxone administration by law enforcement officers in New York State (2015-2020). Pourtaher E, Payne ER, Fera N, Rowe K, Leung SJ, Stancliff S, Hammer M, Vinehout J, Dailey MW. Harm Reduct J. 2022 Sep 19;19(1):102. doi: 10.1186/s12954…

01. November 2022 | Naloxon

Characteristics of events in which police responded to overdoses: an examination of incident reports in Rhode Island.

Characteristics of events in which police responded to overdoses: an examination of incident reports in Rhode Island. Macmadu A, Yolken A, Frueh L, Toussaint JR, Newman R, Jacka BP, Collins AB, Marshall BDL. Harm Reduct J. 2022 Oct 18;…

11. Oktober 2022 | Naloxon

Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation.

Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation. Randall A, Hull I, Martin SA. J Addict Med. 2022 Sep 23. doi: 10.1097/ADM.0000000000001073. Epub ahead of print. PMID: 3614…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten